Market Highlights

• Since its completion in Q4 2024, 222 Fifth Avenue has already drawn several startup tenants with its CoLabs incubator program, which offers biotech startups access to mentors, vendors, and investors.
• Venture capital (VC) funding skyrocketed to $620.5 million in the first quarter of 2025 alone, compared to just over $700 million in total funding for all of 2024.
• Washington Research Foundation (WRF) has committed $10.0 million over five years to SeaBridge, a UW Medicine and Allen Institute program advancing cell and genome reprogramming technologies from the Seattle Hub for Synthetic Biology to combat disease.

Read the full report